Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT06610682
Title	Feasibility of CSF and Plasma ctDNA in BRAF-altered Glioma During Treatment With Plixorafenib
Recruitment	Not yet recruiting
Gender	both
Phase	Phase I
Variant Requirements	Yes
Sponsors	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Indications	central nervous system cancer
Therapies	PLX8394
Age Groups:	senior \| adult
Covered Countries	USA